Electromed Stock Current Ratio
ELMD Stock | USD 14.50 0.56 4.02% |
Electromed fundamentals help investors to digest information that contributes to Electromed's financial success or failures. It also enables traders to predict the movement of Electromed Stock. The fundamental analysis module provides a way to measure Electromed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Electromed stock.
Last Reported | Projected for Next Year | ||
Current Ratio | 4.22 | 4.10 |
Electromed | Current Ratio |
Electromed Company Current Ratio Analysis
Electromed's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Electromed Current Ratio | 4.83 X |
Most of Electromed's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Electromed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Electromed Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Electromed is extremely important. It helps to project a fair market value of Electromed Stock properly, considering its historical fundamentals such as Current Ratio. Since Electromed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Electromed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Electromed's interrelated accounts and indicators.
Click cells to compare fundamentals
Electromed Current Ratio Historical Pattern
Today, most investors in Electromed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Electromed's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Electromed current ratio as a starting point in their analysis.
Electromed Current Ratio |
Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition |
Electromed Price To Sales Ratio
Price To Sales Ratio |
|
In accordance with the recently published financial statements, Electromed has a Current Ratio of 4.83 times. This is 65.98% higher than that of the Health Care Equipment & Supplies sector and 42.06% higher than that of the Health Care industry. The current ratio for all United States stocks is 123.61% lower than that of the firm.
Electromed Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Electromed's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Electromed could also be used in its relative valuation, which is a method of valuing Electromed by comparing valuation metrics of similar companies.Electromed is currently under evaluation in current ratio category among related companies.
Electromed Current Valuation Drivers
We derive many important indicators used in calculating different scores of Electromed from analyzing Electromed's financial statements. These drivers represent accounts that assess Electromed's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Electromed's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 129.3M | 96.7M | 81.7M | 90.6M | 81.6M | 85.7M | |
Enterprise Value | 118.9M | 84.9M | 73.6M | 83.4M | 75.1M | 78.8M |
Electromed Fundamentals
Return On Equity | 0.1 | ||||
Return On Asset | 0.0721 | ||||
Profit Margin | 0.08 % | ||||
Operating Margin | 0.17 % | ||||
Current Valuation | 109.65 M | ||||
Shares Outstanding | 8.61 M | ||||
Shares Owned By Insiders | 26.69 % | ||||
Shares Owned By Institutions | 32.78 % | ||||
Number Of Shares Shorted | 42.93 K | ||||
Price To Earning | 23.66 X | ||||
Price To Book | 3.10 X | ||||
Price To Sales | 2.42 X | ||||
Revenue | 48.07 M | ||||
Gross Profit | 36.52 M | ||||
EBITDA | 4.62 M | ||||
Net Income | 3.17 M | ||||
Cash And Equivalents | 8.15 M | ||||
Cash Per Share | 0.96 X | ||||
Total Debt | 161 K | ||||
Debt To Equity | 0 % | ||||
Current Ratio | 4.83 X | ||||
Book Value Per Share | 4.69 X | ||||
Cash Flow From Operations | 1.31 M | ||||
Short Ratio | 1.06 X | ||||
Earnings Per Share | 0.45 X | ||||
Target Price | 26.0 | ||||
Number Of Employees | 170 | ||||
Beta | 0.42 | ||||
Market Capitalization | 119.96 M | ||||
Total Asset | 45.81 M | ||||
Retained Earnings | 18.79 M | ||||
Working Capital | 29.73 M | ||||
Current Asset | 15.82 M | ||||
Current Liabilities | 3.07 M | ||||
Net Asset | 45.81 M |
About Electromed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Electromed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Electromed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Electromed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Electromed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electromed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromed will appreciate offsetting losses from the drop in the long position's value.Moving together with Electromed Stock
0.89 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
Moving against Electromed Stock
0.88 | IVP | Inspire Veterinary | PairCorr |
0.77 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
0.74 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
0.6 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
0.57 | AHG | Akso Health Group | PairCorr |
The ability to find closely correlated positions to Electromed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electromed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electromed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electromed to buy it.
The correlation of Electromed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electromed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electromed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electromed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Electromed Piotroski F Score and Electromed Altman Z Score analysis. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.727 | Earnings Share 0.45 | Revenue Per Share 6.072 | Quarterly Revenue Growth 0.167 | Return On Assets 0.0721 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.